F-star Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2017 to Q1 2022

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: F-star Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2017 to Q1 2022.
F-star Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $122K, a 15.3% decline year-over-year.
F-star Therapeutics, Inc. annual Depreciation for 2021 was $562K, a 50.9% decline from 2020.
F-star Therapeutics, Inc. annual Depreciation for 2020 was $1.14M, a 35.5% increase from 2019.
F-star Therapeutics, Inc. annual Depreciation for 2019 was $844K, a 193% increase from 2018.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2022		$122K	-$22K	-15.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-10
Q1 2021	$1.11M	$144K	-$36K	-20%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$1.14M	$773K	+$192K	+33%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-15
Q3 2020	$952K	$96K	+$4K	+4.35%	Jul 1, 2020	Sep 30, 2020	10-Q	2020-11-03
Q2 2020	$948K	$95K	+$7K	+7.96%	Apr 1, 2020	Jun 30, 2020	10-Q	2020-08-10
Q1 2020	$941K	$180K	+$97K	+117%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	$844K	$581K			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-30
Q3 2019		$92K	-$15K	-14%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-03
Q2 2019		$88K	+$47K	+115%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019		$83K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q3 2018		$107K	+$68K	+174%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$41K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-31
Q3 2017		$39K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.